Sixfold Bioscience
YC W18London, GB · Founded 2018 · 27 employees · 6 known investors
Find your way into Sixfold Bioscience
1,172 people in our graph share verified history with the Sixfold Bioscience team — schools, employers, funds. One of them is your warm intro.
Elliot Geidtunlockedknows Anna Perdrix Rosell · together at Stanford University Graduate School of Business (overlapped)
×7knows the team · via Universitat de Barcelona
knows the team · via Stanford University Graduate School of Business
×3knows the team · via Cambridge Judge Business School
Sixfold develops RNA delivery technology for the biotech industry. The company was founded by an oncologist and plant scientist and focuses on advancing RNA-based therapeutic approaches through proprietary delivery methods.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesGene TherapyNanomedicineDrug DeliveryUnited KingdomEurope
Founders & leadership· Y Combinator alumni (W18)
Sixfold Bioscience was founded in 2018 by George Foot and Anna Perdrix Rosell.
GF
George FootinFounder/co-CEO
AP
Anna Perdrix RosellinCo-FounderFounder of Sixfold Bioscience, an RNA delivery technology company for biotech. Perdrix Rosell has background training in oncology and plant science.
TF
Tina FlatauNamed on SEC filing
Investors · 6
Pi CampusRome · $55K – $540K
Y CombinatorSan Francisco · $500K
Cantos Venturesreported · 3 sourcesSan Francisco · $400K – $1.5M
Lombardstreet VenturesreportedWoodside · $500K
The Venture CollectivereportedMiami Beach · $100K – $500K
Also in the syndicate · 1
Lombard Street Ventures
Funding
SEC filings, press & company announcements$12.8M disclosed across 2 rounds · 2021
- $10.5MseedDec 2021 · 3 sources
Cantos Ventures, Lombard Street Ventures, Pi Campus, Y Combinator
Source ↗
▶$2.3MraisedAug 2021 · 13 investors · Other TechnologyRule 506(b)
▶$2.3MraisedAug 2021 · 13 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Tina FlatauDirector, Promoter
- Anna Perdrix RosellExecutive Officer, Director, Promoter
- George William FootExecutive Officer, Director, Promoter
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Sixfold Ai9 shared keywordsSixfold provides an AI-powered underwriting platform for insurance carriers, MGAs, and reinsurers to automate and accelerate the underwriting process. The platform processes submissions across multiple business lines and continents, enabling underwriters to focus on complex decisions while AI handles routine work.
Salesforceventures7 shared keywordsSalesforce Ventures is a venture capital firm that invests in enterprise software companies globally, focusing on generative AI, data infrastructure, security, vertical and horizontal applications, and emerging areas like energy and space.
Companies competing with Sixfold Bioscience for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Sixfold Bioscience do?
- Sixfold develops RNA delivery technology for the biotech industry. The company was founded by an oncologist and plant scientist and focuses on advancing RNA-based therapeutic approaches through proprietary delivery methods.
- Who founded Sixfold Bioscience?
- Sixfold Bioscience was founded by George Foot, Anna Perdrix Rosell in 2018.
- Who are Sixfold Bioscience's investors?
- Sixfold Bioscience's investors include Pi Campus, Y Combinator, Cantos Ventures, Lombardstreet Ventures, The Venture Collective.
- How much funding has Sixfold Bioscience raised?
- Sixfold Bioscience has disclosed $12.8M raised across 2 rounds.
- Where is Sixfold Bioscience headquartered?
- Sixfold Bioscience is headquartered in London, GB.